Paragon Capital Management LLC Bristol Myers Squibb CO Transaction History

Paragon Capital Management LLC

$178 Million
Q4 2024

A detailed history of Paragon Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Paragon Capital Management LLC holds 19,241 shares of BMY stock, worth $1.04 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

19,241

Previous 20,045 4.01%

Holding current value

$1.04 Million

Previous $1.04 Million 4.92%

% of portfolio

0.61%

Previous 0.57%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$51.92 - $59.94 $41,743 - $48,191	-804 Reduced 4.01%	19,241 $1.09 Million
Q3 2024 Nov 04, 2024	BUY	$39.66 - $51.75 $9,875 - $12,885	249 Added 1.26%	20,045 $1.04 Million
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $28,336 - $37,304	-704 Reduced 3.43%	19,796 $822,000
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $10,651 - $12,076	222 Added 1.09%	20,500 $1.11 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $1.11 Million - $1.32 Million	-22,830 Reduced 52.96%	20,278 $1.04 Million
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $19,508 - $21,814	-337 Reduced 0.78%	43,108 $2.5 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $35,231 - $39,119	-553 Reduced 1.26%	43,445 $2.78 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $56,247 - $63,797	-856 Reduced 1.91%	43,998 $3.05 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $12,737 - $15,082	-186 Reduced 0.41%	44,854 $3.23 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $167 - $99,046	-1,289 Reduced 2.78%	45,040 $3.2 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $52,068 - $57,345	717 Added 1.57%	46,329 $3.57 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $39,593 - $47,475	644 Added 1.43%	45,612 $3.33 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $74,599 - $86,965	-1,391 Reduced 3.0%	44,968 $2.8 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $117,393 - $137,511	-1,984 Reduced 4.1%	46,359 $2.74 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $40,427 - $44,025	-653 Reduced 1.33%	48,343 $3.23 Million
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $147,519 - $165,915	-2,486 Reduced 4.83%	48,996 $3.23 Million
Q4 2020 Jan 21, 2021	BUY	$57.74 - $65.43 $2.63 Million - $2.98 Million	45,575 Added 771.54%	51,482 $3.19 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $28,232 - $33,006	515 Added 9.55%	5,907 $347,000
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $3,294 - $4,787	71 Added 1.33%	5,392 $301,000
Q1 2019 Apr 15, 2019	BUY	$45.12 - $53.8 $240,083 - $286,269	5,321 New	5,321 $254,000
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $219,876 - $248,004	-3,984 Closed	0 $0
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $13,996 - $17,445	-277 Reduced 6.5%	3,984 $220,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $15,099 - $17,382	252 Added 6.29%	4,261 $269,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $221,417 - $255,533	4,009	4,009 $255,000

Others Institutions Holding BMY

# of Institutions

2,729

Shares Held

1.57B

Call Options Held

30M

Put Options Held

31.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LLC with notifications on news.

Account

Paragon Capital Management LLC Bristol Myers Squibb CO Transaction History